Form 8-K - Current report:
SEC Accession No. 0001437749-25-024956
Filing Date
2025-08-06
Accepted
2025-08-06 08:00:34
Documents
16
Period of Report
2025-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20250805_8k.htm   iXBRL 8-K 33729
2 EXHIBIT 10.1 ex_848590.htm EX-10.1 49416
3 EXHIBIT 99.1 ex_848591.htm EX-99.1 14178
8 diamedicalogo.jpg GRAPHIC 6910
  Complete submission text file 0001437749-25-024956.txt   255272

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dmac-20250804.xsd EX-101.SCH 3578
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20250804_def.xml EX-101.DEF 11411
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20250804_lab.xml EX-101.LAB 15289
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20250804_pre.xml EX-101.PRE 11571
19 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20250805_8k_htm.xml XML 2842
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 251187541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)